18 June 2008
Recently, Genetic Engineering & Biotechnology News (GEN) produced an article discussing the increasing significance of advanced array CGH (aCGH) copy number analysis in molecular diagnostics. One extremely daunting facet of the analysis involves mining the massive datasets produced by large scale, high throughput array technology. In this article, Dr. Anton Petrov, infoQuant CEO and scientific director, discusses the role oneClickCGH and CGH Fusion play in alleviating the burden of accurate aberration detection in clinical diagnostics.
The full article is available on the Genetic Engineering & Biotechnology News website here: